Document:

Exhibit 10.15

 

EMPLOYMENT AGREEMENT

 

THIS AGREEMENT made this 1st day of March, 2021
(the “Effective Date”)

 

BETWEEN:

 

INMED PHARMACEUTICALS INC., a
company incorporated under the laws of British Columbia with offices at Suite 310, 815 West Hastings St., Vancouver, B.C., V6C 1B4 (the
“Company”)

 

AND:

 

SARAH LI (the “Employee”),
of 6957 Cunningham Court, Burnaby, V5E 0B1 BC

 

(each a “Party”
and together, the “Parties”)

 

WHEREAS:

 

		A.	The Company is a clinical stage pharmaceutical company that specializes in developing therapies through
the research and development of novel, cannabinoid-based and other pharmaceutical therapies to treat disease combined with innovative
drug delivery systems;

 

		B.	The Employee has the expertise, qualifications and required certifications to perform the services contemplated
by this Agreement;

 

		C.	The Parties entered into an employment agreement with an effective date of December 11, 2019 (the “Original
Employment Agreement”); and

 

		D.	The Company and the Employee have agreed to set out in writing the terms and conditions of the Employee’s
continued employment.

 

NOW THEREFORE, in consideration of the mutual
covenants and agreements contained in this Agreement, including increased compensation, and other good and valuable consideration, the
receipt and sufficiency of which is hereby acknowledged, the Parties agree as follows:

 

		1	EMPLOYMENT

 

		(a)	Terms of Employment. The Employee will be continue to be employed by, and will continue to serve,
the Company on the terms and conditions set out herein.

 

		(b)	Position and Services. The Employee will hold the position of Controller and will have powers and
duties consistent with such position as may from time to time be prescribed by the Chief Financial Officer of the Company, as outlined
in Exhibit A (the “Services”). The Employee will report directly to the Chief Financial Officer, or designee, and will
comply with all lawful instructions given by the Chief Financial Officer, or designee.

 

		(c)	Term. The terms and conditions of this Agreement will have effect as and from the Effective Date
and the Employee’s employment will continue until terminated as provided for in this Agreement (the “Term”).

 

		(d)	Policies. The Employee’s employment with the Company is subject to and governed by the Company’s
policies as established and amended by the Company from time to time in its sole discretion.

 

		(e)	Performance of Duties. The Employee will perform the Services in a competent and efficient manner
and on an exclusive, full-time basis. The Employee may manage their personal investments activities as long as such activities do not
interfere with the Employee’s performance of their duties to the Company. The Employee will at all times act in good faith to the
Company.

 

     

     

    

 

The Employee may participate
in business associations, charitable organizations or other similar organizations, subject to the reasonable objection of the Company
and provided that it does not interfere with the proper discharge of the Employee’s duties to the Company. However, while employed
by the Company, the Employee must not carry out any other work or be involved in any other business for the Employee or any other person,
firm or company (whether for compensation or not,) without first obtaining written permission from the Company. The Employee represents
that they are not currently involved with any other business for which they must seek such permission.

 

		(f)	Fiduciary. The Employee acknowledges that the Employee will be in a fiduciary relationship with
the Company and will continue to owe fiduciary obligations to the Company. The provisions of this Agreement including the Exhibits are
additional to and do not amend, replace or otherwise reduce the Employee’s fiduciary obligations at law or equity.

 

		(g)	Compliance with the Law. The Employee will that their actions are at all times in compliance with
applicable laws, including without limitation the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), the
Corruption of Foreign Public Officials Act (Canada), and the Foreign Corrupt Practices Act (U.S.).

 

		2	REMUNERATION AND BENEFITS

 

		(a)	Base Salary.

 

		(i)	The Company will pay the Employee an annual salary of CA$138,500, for full-time performance of the Services
(the “Base Salary”). The Base Salary is payable in a manner that is consistent with the Company’s usual payroll
practices for Employees as amended from time to time.

 

		(ii)	The Employee’s Base Salary will be reviewed annually by the Management Team, Board and the compensation
committee of the Company in accordance with the Company’s annual performance and compensation review process, including consideration
of the Company’s market capitalization and financial stability. Any increase in Base Salary is at the sole discretion of the Company.
An increase in the Base Salary in any year or any number of years does not entitle the Employee to any increase in the Base Salary in
any subsequent year.

 

		(b)	Bonus. The Employee is eligible to be considered for an annual discretionary bonus which will be
subject to the approval of the Board and the compensation committee of the Company, in their sole discretion, on an annual basis in accordance
with the Company’s annual performance and compensation review process, including consideration of the Company’s market capitalization
and financial stability. Payment of a bonus in any one year or any number of years will not entitle the Employee to any payment of a bonus
in any subsequent year. The target annual discretionary bonus for the Employee is equal to 25% of Base Salary (the “Target Bonus”).

 

		(c)	Stock Options. The Company may from time to time in its sole discretion grant to the Employee stock
options in the capital of the Company (the “Options”) pursuant to the Company’s Incentive Stock Option Plan (the
“SOP”) on the terms and conditions for such participation as established and changed from time to time by the Company
in its sole discretion. For clarity, any Options that are granted will be granted at the market price in accordance with and subject to
the options policies of the applicable exchange and will be subject to the Company’s Insider Trading Guidelines including the blackout
provisions therein. The terms and conditions relating to the Options will be subject to the Option Agreement that is entered into as a
condition of the grant of the Options. If there is any conflict between the terms of this Agreement and the SOP, the terms of the SOP
will govern. If there is any conflict between the terms of this Agreement and the Option Agreement, the terms of this Agreement will govern
to the extent of the conflict.

 

    Page 2 of 28

     

    

 

The Employee will retain
any outstanding stock options that were granted to the Employee prior to the Effective Date on the same terms as set out in the Option
Agreement and the SOP. The Employee’s outstanding stock options as of the Effective Date are as follows:

 

	Date of Grant	 	Number of 

Options	 	Expiry Date	 
	12-Jan-20	 	 	3,030	 	 	11-Jan-25	 
	12-Jan-20	 	 	3,030	 	 	11-Jan-25	 
	16-Dec-20	 	 	2,000	 	 	15-Dec-25	 

 

		(d)	Expenses. The Company will reimburse the Employee for all reasonable expenses actually and properly
incurred by the Employee in performing services under this Agreement, in accordance with the policies and procedures then in effect and
established by the Company for its senior Employees as amended by the Company from time to time in its sole discretion.

 

		(e)	Other Benefits. The Company will facilitate the Employee’s continued enrolment in the Company’s
insured benefits plans as amended from time to time by the Company in its sole discretion or by the Company’s insurance carrier.
Eligibility to participate in the plans and to receive benefits under the plans, and the payment of benefits will be subject to the terms
and requirements of the applicable insurance carrier in accordance with the formal benefits plan documents and policies. The Company’s
financial liability is limited to paying its portion of the premium cost of the benefits. The Company will not be responsible for the
payment of benefits in any circumstance. The Company reserves the right, in its sole discretion, to amend, change or terminate any of
the insurance benefit plans or providers in whole or in part at any time.

 

		(f)	Vacation. The Employee is entitled to paid holidays and vacation days each year, in an amount determined
in accordance with and subject to the Company’s applicable policies in effect, and as may be amended from time to time. The Employee
will be entitled to 25 days of vacation per calendar year, which will be pro-rated for partial years of service, including for any period
in which the Employee is not a full-time employee. Vacation days will be scheduled at times that are mutually acceptable to the Employee
and the Company. Carry-over of vacation days will be according to Company policy, and any accrued but unused vacation days will be paid
out upon termination or otherwise as per Company policies, as amended by the Company from time to time in its sole discretion.

 

		3	COVENANTS

 

		(a)	Competition. During the Term, the Employee will not compete with the Company in any manner whatsoever.

 

		(b)	Confidentiality and Intellectual Property Agreement. The Employee and the Company will enter into
a Confidentiality and Assignment of Inventions Agreement in the form attached hereto as Exhibit B.

 

    Page 3 of 28

     

    

 

		(c)	Restrictive Covenant Agreement. The Employee will execute and abide by the Restrictive Covenant
Agreement attached hereto as Exhibit C.

 

		(d)	Acknowledgement. The Employee acknowledges that the consideration provided by the Company under
this Agreement, including without limitation an increase in the Base Salary, is in part in exchange for the Employee’s agreement
to execute and abide by the Exhibits B and C to this Agreement, and that the Employee has received sufficient consideration for the Employee’s
agreement to execute and abide by those Exhibits.

 

		4	TERMINATION

 

		(a)	Definitions. In this Agreement,

 

		(i)	“Date of Termination” means:

 

		(A)	if the Employee’s employment is terminated by their death, the date of death;

 

		(B)	if the Employee’s employment is terminated by the Company for any reason, on the effective date
of the Notice of Termination that is given to the Employee; or

 

		(C)	if the Employee terminates their employment under section 6, on the effective date of resignation specified
by the Employee in the Notice of Termination subject to the Company’s rights pursuant to section 6.

 

		(ii)	“Disability” means the inability of the Employee to substantially perform the Services
on a full-time basis for a continuous or cumulative period of six months in any 18-month period where such inability is a result of physical
or mental illness or injury and where it would cause undue hardship to the Company to accommodate.

 

		(iii)	“Just Cause” means:

 

		(A)	the Employee is convicted of a crime involving dishonesty, breach of trust, or physical harm to any person
(excluding driving while affected by drugs or alcohol) or any violation of provincial or federal securities laws,

 

		(B)	the Employee willfully engages in conduct that is in bad faith and/or materially injurious to the Company,
monetarily, reputationally, or otherwise, including but not limited to, misappropriation of trade secrets, fraud, embezzlement or moral
turpitude,

 

		(C)	the Employee commits a material breach of this Agreement including the Exhibits,

 

		(D)	the Employee willfully and on a continuing basis refuses to implement or follow a material lawful policy
or reasonable directive of the Company, or

 

		(E)	the Employee willfully and on a continuing basis fails to perform their duties hereunder diligently and
professionally; or

 

		(F)	the Employee engages in any other conduct that constitutes just cause to terminate the employment relationship
at common law; and

 

    Page 4 of 28

     

    

 

		(iv)	“Notice of Termination” means a written notice by the Company or the Employee that
provides the other party with notice of termination of the employment under this Agreement and indicates the specific termination provision
in this Agreement upon which the termination is based.

 

		(b)	Termination. The Employee’s employment with the Company may be terminated as follows:

 

		(i)	by the Company for Just Cause;

 

		(ii)	by the Company in its sole discretion without Just Cause subject to providing the payments and entitlements
set out in section 5 of this Agreement;

 

		(iii)	by the Employee as provided for in section 6 of this Agreement;

 

		(iv)	by the Company following receipt of a Notice of Termination by the Employee as contemplated in section
6 of this Agreement;

 

		(v)	by the Employee’s death, in which case a Notice of Termination will be deemed to have been given
by the Employee to the Company as of the Date of Termination; or

 

		(vi)	by the Company as a result of Disability, but nothing in this section 4(b)(vi) will reduce the Employee’s
rights, if any, under the Company’s insurance benefits plans accruing prior to termination or under applicable law,

 

and the Company shall
pay or provide to the Employee (or the authorized representative or estate of the Employee if applicable) any earned but unpaid Base Salary,
unpaid expense reimbursements validly incurred by the Employee, accrued but unused vacation subject to Company policy, any vested benefits
the Employee may have under any employee benefit plan of the Company, and any earned but unpaid annual bonus for the prior fiscal year,
that is due and owing for Services provided up to and including the Date of Termination (collectively the “Accrued Benefits”).
If the termination is initiated by the Company, the Company will also provide the notice of termination or wages in lieu of notice owing
pursuant to the minimum requirements of the B.C. Employment Standards Act (the “ESA Entitlement”).

 

		(c)	Return of Materials. The Employee will return to the Company all Company documents, files, manuals,
books, software, equipment, keys, identification or credit cards, and all other property belonging to Company, including electronic devices
and any necessary passwords and encryption codes immediately upon the termination of the Employee’s employment with the Company
for any reason.

 

		(d)	Release. In order to receive the entitlements set out in this Agreement that are in excess of the
ESA Entitlement, the Employee, or the estate of the Employee as applicable, will be required, within 14 days of the Date of Termination,
to sign and return a Release in the form attached as Exhibit D to this Agreement (the “Release”) failing which the
Employee will only be entitled to the ESA Entitlement, if any. For clarity, if the Employee does not sign and return the Release to the
Company, then the Employee will still be bound by the provisions of this Agreement, including each of the obligations set out in the Exhibit
B and C.

 

		(e)	Full Satisfaction. The amounts payable to the Employee pursuant to the express terms of this Agreement,
if any, constitute full and final satisfaction of the Employee’s rights and entitlements in connection with the termination of the
Employee’s employment, including without limitation pursuant to the B.C. Employment Standards Act (“ESA”) and
the common law, and the Company shall have no further obligation or liability of any kind for any claim, action, complaint, or demand
whatsoever, whether at law or equity, under contract, or under any legislation from time to time applicable and in force or otherwise,
for any remedy, damages, or loss sustained or sought by the Employee arising out of the employment of the Employee by the Company or the
termination of that Employment.

 

    Page 5 of 28

     

    

 

		5	TERMINATION WITHOUT JUST CAUSE

 

If the Employee’s
employment is terminated by the Company without Just Cause pursuant to section 4(b)(ii), then in addition to the ESA Entitlement and the
payment of any Accrued Benefits, and subject to the Employee first providing the Company with an executed Release pursuant to section
4(e), the Company shall pay the Employee an amount (the “Severance Amount”) calculated as follows:

 

		(a)	if terminated within two (2) years of the effective date of the Original Employment Agreement, six (6)
months’ Base Salary less an amount equal to the ESA Entitlement provided by the Company to the Employee; less withholdings; or

 

		(b)	if terminated any time after the two (2) year anniversary of the effective date of the Original Employment
Agreement, six (6) month’s Base Salary plus one month for each additional full year of employment in excess of two years to a maximum
of 12 months month’s Base Salary, less an amount equal to the ESA Entitlement provided by the Company to the Employee, less withholdings;
and

 

		(c)	in addition to the amount payable under section 5(a) or 5(b), a bonus payment equal to the average of
the actual annual bonus payments, if any, made to the Employee from the previous 3 calendar years preceding the Date of Termination, pro-rated
for the then current calendar year up to and including the Date of Termination.

 

The Company shall
pay the Severance Amount within 5 business days after the date that the Company receives the signed Release as per section 4(e) of this
Agreement, provided that the Company, in its sole discretion, may pay the Severance Amount by way of one or more lump sum payments, by
way of salary continuance or by a combination of both.

 

		6	RESIGNATION WITHOUT GOOD REASON

 

The Employee may terminate
their employment by providing to the Company Notice of Termination of their employment at least 90 days prior to the effective date of
resignation. During such notice period, the Employee shall continue to diligently perform all of the Employee’s duties. Upon receipt
of a Notice of Termination from the Employee pursuant to this section 6, the Company may, at its option:

 

		(a)	direct that the Employee cease providing part or all of the Services and such direction will not constitute
an express or constructive termination of the employment of the Employee by the Company, provided that the Company will remain bound to
pay the Base Salary for the balance of the notice period provided by the Employee; or

 

		(b)	terminate the employment of the Employee at any time within the notice period, including where the Company
first elects to proceed with the option under section 6 (a) above, in which case, unless the termination is for Just Cause, the Company
will pay the Employee only the lesser of either (i) an amount equal to the Base Salary from the date the Employee provided the Notice
of Termination until the earlier of the date of resignation or retirement selected by the Employee and 90 days from the date the Employee
provided the Notice of Termination, and (ii) the ESA Entitlement.

 

For clarity, if the
Company elects to terminate the employment of the Employee after receiving Notice of Termination from the Employee, the Company will not
owe the Employee the Severance Amount and all benefits coverage will cease as of the Date of Termination set out in the Employer’s
Notice of Termination.

 

    Page 6 of 28

     

    

 

		7	Stock Option Plan (SOP) Entitlements

 

		(a)	On a termination of the employment of the Employee for any reason and whether initiated by the Company
or the Employee, the rights of the Employee with respect to any Option will be determined in accordance with the SOP and the applicable
Option Agreement.

 

		(b)	Acknowledgement: The Employee acknowledges and agrees that the provisions
of this Agreement and the SOP may significantly limit and restrict the Employee’s common law rights and entitlements to remuneration
upon the termination of the Employee’s employment for any reason, whether the termination is voluntary or involuntary, and whether
the termination was initiated by the Employee, by the Company, or otherwise, and that the Employee has had a reasonable opportunity to
review these provisions and seek legal advice.

 

Initial Here: _________

 

		8	GENERAL

 

		(a)	Withholdings and Currency. All payments made by the Company to the Employee under this Agreement
will be in Canadian dollars and subject to tax or other amounts required to be withheld by the Company under applicable law. Nothing in
this Agreement is to be construed to obligate the Company to design or implement any compensation arrangement in a way that minimizes
tax consequences for the Employee.

 

		(b)	Remedies. The Employee acknowledges that damages cannot be an adequate remedy to compensate the
Company for any actual or anticipatory breach by the Employee of section 1(e) of this Agreement or Exhibits B and C. In the event of a
breach or anticipatory breach by the Employee of the provisions of section 1(e) of this Agreement or the Exhibits B and C, the Company
will be entitled to interim, interlocutory and permanent injunctions restraining the Employee from such breach. Nothing contained herein
will be construed as prohibiting the Company from pursuing any other remedies available at law or equity for such breach or anticipatory
breach of this Agreement including the Exhibits nor limiting the amount of damages recoverable in the event of a breach or anticipatory
breach by the Employee of the provisions of section 1(e) of this Agreement or the Exhibits B and C. Without limiting the generality of
the foregoing, the Employee acknowledges that, in the event of a breach or threatened breach by the Employee of any of the provisions
of section 1(e) of this Agreement or the Exhibits B and C, the damages of the Company may exceed the amount paid to the Employee pursuant
to this Agreement. If the Employee breaches any provision of this Agreement, then despite any term or condition to the contrary and without
limitation to any remedy the Company may be entitled to, any entitlement of the Employee to remuneration that has not yet been paid or
provided is immediately terminated except and only to the extent that the compensation is minimally owing under the ESA or any other applicable
legislation.

 

    Page 7 of 28

     

    

 

		(c)	Assignment and Benefit. The Employee will not assign or transfer this Agreement or any rights or
obligations hereunder. The Company may assign this Agreement to any successor to the Company and in the event of such an assignment the
provisions hereof will inure to the benefit of, and be binding upon, each successor of the Company, whether the successor arises by merger,
consolidation or transfer of all or substantially all of its assets. This Agreement shall inure to the benefit of and be enforceable by
the Employee’s successors and legal representatives.

 

		(d)	Non-Waiver. Failure on the part of either party to complain of any act or failure to act of the
other of them or to declare the other party in default of this Agreement, irrespective of how long such failure continues, will not constitute
a waiver by such party of their rights hereunder or of the right to then or subsequently declare a default.

 

		(e)	Severability. If any provision in this Agreement including the Exhibits is found to be invalid
or unenforceable, then to the greatest extent permitted by law the scope of any unenforceable provision will be deemed modified and diminished
by the Parties to the minimum extent necessary to render such provision valid and enforceable, and in any event the invalidity or unenforceability
of any such provision will not affect the validity or enforceability of any other provision of this Agreement including the Exhibits.

 

		(f)	Entire Agreement. This Agreement, including the Exhibits and any Option Agreements, constitutes
the entire agreement between the parties with respect to the employment of the Employee and supersedes any and all agreements, understandings,
warranties or representations of any kind, written or oral, express or implied, including any relating to the nature of the position or
its duration in including the Original Employment Agreement, and each of the parties releases and forever discharges the other of and
from all manner of actions, causes of action, claim or demands whatsoever under or in respect of any agreement.

 

		(g)	Survival. The provisions of sections 1(f) and 3 to 9 inclusive this Agreement and the Exhibits
survive the termination of this Agreement and/or the termination of the Employee’s employment to the extent necessary to effectuate
the intent of the Parties as expressed in this Agreement.

 

		(h)	Modification of Agreement. Any modification of this Agreement must be in writing and signed by
both the Company and the Employee or it will have no effect and will be void.

 

		(i)	Headings and Sub-Headings. Descriptive headings and sub-headings are for convenience only and will
not control or affect the meaning or construction of any provision of this Agreement.

 

		(j)	Disputes. All disputes arising out of or in connection with this Agreement and the employment
relationship between the parties, including the Exhibits, are to be referred to and finally resolved by a single arbitrator pursuant to
the Domestic Commercial Rules of Procedure of the British Columbia International Commercial Arbitration Centre. The place of arbitration
will be Vancouver, British Columbia.

 

Either Party may apply
to the arbitrator for injunctive relief until the arbitration award is rendered or the controversy is otherwise resolved. Before an arbitrator
is appointed or makes a final determination on the merits of the controversy, either Party also may, without waiving any remedy under
this Agreement, seek from any court of competent jurisdiction in British Columbia sitting in Vancouver any interim or provisional relief
that is necessary to protect the rights or property of that Party.

 

Any decision of the
Arbitrator shall be final and binding on the Parties and their respective successors and assigns and there shall be no right to appeal
such decision, whether on a question of law, a question of fact, or a mixed question of law or fact.

 

    Page 8 of 28

     

    

 

Each Party shall bear
its own costs of any arbitration proceedings commenced pursuant to this Agreement, including legal and travel costs, and the Parties shall
equally share the fees of the Arbitrator and the facility fees.

 

The Arbitration procedures,
hearings, documents, and award shall remain strictly confidential between the Parties.

 

Acknowledgement:
The Employee acknowledges and agrees that the Employee has had a reasonable opportunity to review this arbitration provision, inquire
about the nature and extent of the costs of arbitration and seek legal advice.

 

Initial Here: _________

 

		(k)	Governing Law and Language. This Agreement will be governed by and construed according to the laws
of the Province of British Columbia and the laws of Canada applicable therein.

 

		(l)	Notices. Any notices, requests, demands, and other communications provided for by this Agreement
are sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or
certified mail, postage prepaid, return receipt requested, to the Employee at the last address the Employee has filed in writing with
the Company or, in the case of the Company, at its main offices, attention to the Corporate Secretary.

 

		(m)	Collection and Use of Personal Information. The Employee acknowledges that the Company will collect,
use and disclose health and other personal information for employment and business related purposes. The Employee consents to the Company
collecting, using and disclosing health and other personal information of the Employee for employment and business related purposes in
accordance with the privacy policy of the Company.

 

		(n)	Minimum Requirements. Nothing in the Agreement is intended to contract out of any minimal substantive
or procedural entitlements or rights that the Employee may have under the ESA, B.C. Human Rights Code or any other applicable legislation.
If any provision in the Agreement provides the Employee with an entitlement that does not meet what the Employee is minimally entitled
to under the ESA, Human Rights Code or any other applicable legislation, then the provision is deemed modified so that the
Employee receives the minimum entitlement required under the ESA, Human Rights Code or any other applicable legislation.

 

		(o)	Independent Legal Advice. The Employee agrees that the Employee has obtained or has had an opportunity
to obtain independent legal advice in connection with this Agreement, and further acknowledges that the Employee has read, understands,
and agrees to be bound by all of the terms and conditions contained herein. The Employee further agrees that the consideration described
aforesaid is accepted voluntarily for the purpose of employment with the Company under the terms and conditions described herein.

 

		(p)	Use of Discretion: Where this Agreement or Exhibits grant the Company a discretionary power,
the Company will be entitled to exercise that power in its sole and absolute discretion for the best interests of the business of Company
except that any discretion exercisable with respect to the Restrictive Covenant Agreement must be exercised reasonably.

 

		(q)	Counterparts. This Agreement may be executed in any number of counterparts, and by each party on
separate counterparts, each of which counterparts, when so executed and delivered is to be taken to be an original; but those counterparts
together constitute one and the same document. PDF, facsimile, scanned, and electronic signatures have the same legal effect as original
ink signatures.

 

    Page 9 of 28

     

    

 

IN WITNESS WHEREOF, the Parties
hereto have duly executed this Agreement, and the Employee has initialed where indicated above, as of the day and year first
written above.

 

	INMED PHARMACEUTICALS INC	 	SARAH LI
	 	 	 
	 	 	 
	 	 	 
	Authorized Signatory	 	 

 

    Page 10 of 28

     

    

 

 

 

Exhibit A –
Services

 

Controller Duties
and Responsibilities.

 

ESSENTIAL DUTIES
AND RESPONSIBILITIES

 

The Employee will perform the
services normally or usually associated with the position and such other or different duties as may be from time to time delegated to
the Employee by the Company in its sole discretion, including without limitation:

 

		●	Manage and monitor all accounts, ledgers, and reporting systems ensuring compliance with appropriate GAAP
standards and regulatory requirements as well as the requirements of private contributions, loans, and government contracts

 

		●	Guides financial decisions by establishing, monitoring, and enforcing policies and procedures.

 

		●	Taking the lead on preparation of annual budget

 

		●	Preparation of workpapers supporting the annual tax returns

 

		●	Coordinate the preparation of annual tax returns with outside CPA firm

 

		●	Preparation of workpapers supporting the monthly close process and month end balances

 

		●	Review monthly accounting close process including analytical review of the monthly operating results to ensure
accurate accounting records are maintained

 

		●	Preparation of quarterly financial statements and related footnotes in accordance with either, or both, US
GAAP and IFRS

 

		●	Manage the relationship with outside auditors

 

		●	Facilitate quarterly reviews and annual audit by outside CPA firm

 

		●	Preparation of monthly reforecast incorporating historical results and future assumptions

 

		●	Preparation of semi-monthly payroll and supervision of all accounts payable

 

    Page 11 of 28

     

    

 

		●	Implement, document and maintain adequate and effective internal controls

 

		●	Implement, document and maintain adequate and effective processes to improve the close and reporting cycles
to ensure timely and accurate reporting

 

		●	Assist with securities commissions and stock exchanges compliance matters

 

		●	Prepare quarterly variance analysis of actual versus budgeted results

 

		●	Assist the CFO with overall risk management activities

 

		●	Manage insurance coverages including relationship with external broker

 

		●	Manage external virtual data-room

 

		●	Assist with the preparation of materials for quarterly Board meetings and Board committee meetings

 

		●	Manage administration of the stock option plan including stock based compensation

 

		●	Assist the CFO with corporate governance matters including various Corporate Secretary activities, AGM circular
and AIF

 

		●	Manage employee benefits plan

 

		●	Any other responsibilities that may be assigned from time to time

 

		●	Other projects as may be assigned from time-to-time by the Chief Financial Officer and other Executives
of the Company.

 

    Page 12 of 28

     

    

 

Exhibit B –
Confidentiality and Assignment of Inventions Agreement

 

Dated: March 1,
2021

 

		WHEREAS:	

 

		A.	In accordance with the terms of the Employment Agreement between the Employee and the Company dated March
1, 2021 (the “EA”), the Employee has agreed to execute this Confidentiality and Assignment of Inventions Agreement
on the terms set out herein.

 

NOW THEREFORE for good and valuable
consideration, including the consideration contemplated by the EA, the receipt and sufficiency of which is acknowledged by the Employee,
the Employee and the Company agree as follows:

 

		1	INTERPRETATION

 

The capitalized terms
have the meanings ascribed to them in the EA, and the following terms have the following meanings:

 

		(a)	“Affiliate” means, in respect of the Company, a company or other entity which directly
or indirectly controls, is controlled by, or is under common control with, the Company. For the purposes of this definition, “control”
means direct or indirect beneficial ownership of a greater than 50% interest in the income of such company or entity or such other relationship
as, in fact, constitutes actual control.

 

		(b)	“Business” or “Business of the Company” means:

 

		(i)	researching, developing, commercializing, producing and marketing novel, cannabinoid-based and other pharmaceutical
therapies to treat disease combined with innovative drug delivery systems; or

 

		(ii)	any other area in which the Company has an active research and development program on the date the Employee’s
employment with the Company terminates and in connection with which the Employee directly provided Services or had direct supervisory
responsibilities.

 

		(c)	“Confidential Information” shall mean all information, knowledge, or data, whether
in written, oral, electronic or other form, relating to the Business of the Company, whether or not conceived, originated, discovered
or developed in whole or in part by the Employee, that is not generally known to the public or to other persons who are not bound by obligations
of confidentiality and:

 

		(i)	from which the Company or its Affiliates derive economic value, actual or potential, from the information
not being generally known; or

 

		(ii)	in respect of which the Company or its Affiliates otherwise have a legitimate interest in maintaining
secrecy;

 

and which, without limiting
the generality of the foregoing, shall include:

 

		(iii)	all proprietary information licensed to, acquired, used or developed by the Company and its Affiliates
in its research and development activities (including but not restricted to the research and development of cannabinoid-based and other
pharmaceutical therapeutics and delivery technology), other scientific strategies and concepts, designs, know-how, information, material,
formulas, processes, research data and proprietary rights in the nature of copyrights, patents, trademarks, licenses and industrial designs;

 

    Page 13 of 28

     

    

 

		(iv)	all information relating to the Business of the Company, and to all other aspects of the structure, personnel
and operations of the Company and its Affiliates, including financial, clinical, regulatory, marketing, advertising and commercial information
and strategies, customer lists, compilations, agreements and contractual records and correspondence; programs, devices, concepts, inventions,
designs, methods, processes, data, know-how, unique combinations of separate items that is not generally known and items provided or disclosed
to the Company or its Affiliates by third parties subject to restrictions on use or disclosure;

 

		(v)	all know-how relating to the Business of the Company, including all biological, chemical, pharmacological,
toxicological, pharmaceutical, physical and analytical, clinical, safety, manufacturing and quality control data and information, and
all applications, registrations, licenses, authorizations, approvals and correspondence submitted to regulatory authorities;

 

		(vi)	all information relating to the businesses of competitors of the Company or its Affiliates, including
information relating to competitors’ research and development, intellectual property, operations, financial, clinical, regulatory,
marketing, advertising and commercial strategies, that is not generally known;

 

		(vii)	all information provided to the Company or its Affiliates by their agents, consultants, lawyers, contractors,
licensors or licensees and relating to the Business of the Company; and

 

		(viii)	all information relating to the Employee’s compensation and benefits, including salary, vacation,
stock options, perquisites, severance notice, rights on termination and all other compensation and benefits, except that the Employee
shall be entitled to disclose such information to the Employee’s bankers, advisors, agents, consultants and other third parties
who have a duty of confidence to the Employee and who have a need to know such information in order to provide advice, products or services
to the Employee.

 

All Work Product shall
be deemed to be the Company’s Confidential Information.

 

Notwithstanding the
foregoing, “Confidential Information” does not include information which the Employee can prove is information that was in
the public domain at the date of disclosure to the Employee, or thereafter entered the public domain through no fault of the Employee
(but only after it has entered the public domain) provided that any combination of information that is Confidential Information will not
be included within the exception merely because parts of the information were within the public domain unless the whole of the combination
itself was in the public domain.

 

		(d)	“Intellectual Property” is used in its broadest sense and means and includes any statutory,
common law, equitable, contractual or proprietary rights or interests, recognized currently or in future, in and to any Inventions, including,
without limitation, rights and interests in and to the following:

 

		(i)	knowledge, know-how and its embodiments, including trade secret information;

 

		(ii)	patents in inventions, and all applications therefor;

 

    Page 14 of 28

     

    

 

		(iii)	copyrights in artistic, literary, dramatic, musical, and neighbouring works, copyrightable works of authorship
including technical descriptions for products, user guides, illustrations, advertising materials, computer programs, source code and object
code, and all applications therefor;

 

		(iv)	trademarks, service marks, tradenames, business names and domain names and all applications therefor;

 

		(v)	industrial designs and all other industrial or intellectual property and all applications therefor; and

 

		(vi)	all goodwill connected with the foregoing.

 

		(e)	“Inventions” shall mean any and all inventions, discoveries, developments, enhancements,
improvements, concepts, formulas, designs, processes, ideas, writings and other works, whether or not reduced to practice, and whether
or not protectable under patent, copyright, trade secret or similar laws.

 

		(f)	“Work Product” shall mean any and all Inventions and possible Inventions relating to
the Business of the Company and which the Employee may make or conceive, alone or jointly with others, during their involvement in any
capacity with the Company, whether during or outside their regular working hours, except those Inventions made or conceived by the Employee
entirely on their own time that do not relate to the Business of the Company and do not derive from any equipment, supplies, facilities,
Confidential Information or other information, gained, directly or indirectly, from or through their involvement in any capacity with
the Company.

 

		2	CONFIDENTIALITY

 

		(a)	Property of the Company. The Company shall exclusively own all right, title and interest in and
to the Confidential Information, whether or not created or developed by the Employee.

 

		(b)	Prior Business Confidential Information. The Employee represents and warrants to the Company that
the Employee has not brought or used, and the Employee covenants and agrees that the Employee will not use or bring to the Company any
confidential information of any kind whatsoever of any prior party (the “Prior Business”) with whom the Employee was
previously involved, whether such involvement was as an employee, director or officer of that Prior Business, an investor in that Prior
Business, a partner in that Prior Business, a consultant to that Prior Business or other relationship to that Prior Business (the “Prior
Involvement”). The Company and the Employee acknowledge and agree that the Company is not employing the Employee to obtain confidential
information relating to any Prior Involvement and the Employee acknowledges that the Company has advised the Employee to comply with any
and all legal obligations the Employee may have to such Prior Business. The Employee covenants and agrees to indemnify and hold the Company
harmless from any and all loss, claims, damages, expenses and costs (including legal costs on a solicitor-client basis) of any kind whatsoever
that the Company may suffer related to of any breach by the Employee of their obligations to such Prior Business in that regard.

 

    Page 15 of 28

     

    

 

		(c)	Basic Obligation of Confidentiality. The Employee hereby acknowledges and agrees that the Company
has disclosed and will continue to disclose to the Employee, and that the Employee has had and will continue to have access to Confidential
Information. The Employee will receive and hold all Confidential Information on the terms and conditions set out in this Exhibit B. Except
as otherwise expressly set out in this Exhibit B, the Employee will keep strictly confidential all Confidential Information and all other
information belonging to the Company that the Employee acquires, observes or is informed of, directly or indirectly, in connection with
the Employee’s involvement, in any capacity, with the Company both during and after the employment in any capacity with the Company.

 

		(d)	Non-Disclosure. Except with the prior written consent of the Company or as may be expressly required
in the course of performing the Services, the Employee will not at any time, either during or after their employment in any capacity with
the Company;

 

		(i)	use or copy any Confidential Information or recollections thereof for any purpose other than the performance
of the Services for the benefit of the Company and its Affiliates;

 

		(ii)	publish or disclose any Confidential Information or recollections thereof to any person other than to
employees of the Company and its Affiliates who have a need to know such Confidential Information in the performance of their duties for
the Company or its Affiliates;

 

		(iii)	permit or cause any Confidential Information to be used, copied, published, disclosed, translated or adapted
except as otherwise expressly permitted by this Agreement; or

 

		(iv)	permit or cause any Confidential Information to be stored off the premises of the Company, including permitting
or causing such Confidential Information to be stored in electronic format on personal computers, except in accordance with written procedures
of the Company, as amended from time to time in writing.

 

		(e)	Taking Precautions. The Employee will take all reasonable precautions necessary or prudent to prevent
material in their possession or control that contains or refers to Confidential Information from being discovered, used or copied by third
parties.

 

		(f)	Control of Confidential Information and Return of Information. All physical materials produced
or prepared by the Employee containing Confidential Information, including, without limitation, records, devices, computer files, data,
notes, reports, proposals, lists, correspondence, specifications, drawings, plans, materials, accounts, reports, financial statements,
estimates and all other materials prepared in the course of their responsibilities to or for the benefit of the Company or its Affiliates,
together with all copies thereof (in whatever medium recorded), shall belong exclusively to the Company, and the Employee will promptly
turn over to the Company’s possession every original and copy of any and all such items in their possession or control upon request
by the Company. If the material is such that it cannot reasonably be delivered, upon request from the Company, the Employee will provide
reasonable evidence that such materials have been destroyed, purged or erased.

 

		(g)	Purpose of Use. The Employee agrees that they will use Confidential Information only for purposes
authorized or directed by the Company.

 

		(h)	Exemptions. The obligations of confidentiality set out in this Section 2 will not apply to

 

		(i)	information required by operation of law, court order or government agency to be disclosed, provided that:

 

		(ii)	in the event that the Employee is required to disclose such information or material, upon becoming aware
of the obligation to disclose, unless prohibited by law the Employee will provide to the Company prompt written notice so that the Company
may seek a protective order or other appropriate remedy and/or waive compliance with the provisions of this Agreement;

 

    Page 16 of 28

     

    

 

		(iii)	if the Company agrees that the disclosure is required by law, it will promptly give the Employee written
authorization to disclose the information for the required purposes only;

 

		(iv)	if the Company promptly informs the Employee that the Company does not agree that the disclosure is required
by law, this Agreement will continue to apply, except to the extent that a Court of competent jurisdiction orders otherwise; and

 

		(v)	if a protective order or other remedy is not obtained or if compliance with this Agreement is waived,
the Employee will furnish only that portion of the Confidential Information that is legally required and will exercise all reasonable
efforts to obtain confidential treatment of such Confidential Information.

 

		3	INTELLECTUAL PROPERTY RIGHTS

 

		(a)	Property of the Company: All Inventions and Work Product will be the sole and exclusive property
of the Company.

 

		(b)	Notice of Invention. The Employee will promptly and fully inform the Company of all Work Product,
whether or not patentable, throughout the course of their involvement, in any capacity with the Company and from which there is a reasonable
basis to believe that Intellectual Property may be derived therefrom, whether or not developed before or after execution of this Agreement.
On their ceasing to be employed by the Company for any reason whatsoever, the Employee will immediately deliver up to the Company all
Work Product.

 

		(c)	Assignment of Rights. Subject only to the exceptions set out in Attachment 1 attached to this Exhibit
B, the Employee will irrevocably assign, and does hereby irrevocably assign, to the Company or, at the option of the Company and upon
notice from the Company, to the Company’s designee, all of their right, title and interest in and to all Work Product, including
all Intellectual Property rights therein. To the extent that the Employee retains or acquires legal title to any such Intellectual Property
rights and interests, the Employee hereby declares and confirms that such legal title is and will be held by them only as trustee and
agent for the Company or the Company’s designee until such time as the Employee is able to execute a binding assignment of such
rights. The Employee agrees that the Company’s rights hereunder shall attach to all Intellectual Property rights in their Work Product,
notwithstanding that it may be perfected or reduced to specific form after they have terminated their relationship with the Company. The
Employee further agrees that the Company’s rights hereunder are worldwide rights and are not limited to Canada, but shall extend
to every country of the world.

 

		(d)	Moral Rights. Without limiting the foregoing, the Employee hereby irrevocably waives any and all
moral rights worldwide, including without limitation those arising under the Copyright Act (Canada), as amended, or any successor
legislation of similar force and effect or similar legislation in other applicable jurisdictions or at common law that they may have with
respect to all Work Product, and agrees never to assert any moral rights which they may have in the Work Product, including, without limitation,
the right to the integrity of the Work Product, the right to be associated with the Work Product, the right to restrain or claim damages
for any distortion, mutilation or other modification or enhancement of the Work Product and the right to restrain the use or reproduction
of the Work Product in any context and in connection with any product, service, cause or institution, and the Employee further confirms
that the Company may use or alter any Work Product as the Company sees fits in its absolute discretion.

 

    Page 17 of 28

     

    

 

		(e)	Goodwill. The Employee hereby agrees that all goodwill that the Employee has established or may
establish with clients, customers, suppliers, principals, shareholders, investors, collaborators, strategic partners, licensees, contacts
or prospects of the Company relating to the Business of the Company (or of its partners, subsidiaries or affiliates), both before and
after the Effective Date, shall be and remain the property of the Company exclusively, for the Company to use, alter, vary, adapt and
exploit as the Company shall determine in its discretion.

 

		(f)	Assistance. The Employee hereby agrees to reasonably assist the Company, at the Company’s
request and expense, in:

 

		(i)	making patent applications for all Work Product, including instructions to lawyers and/or patent agents
as to the characteristics of the Work Product in sufficient detail to enable the preparation of a suitable patent specification, to execute
all formal documentation incidental to an application for letters patent and to execute assignment documents in favour of the Company
for such applications;

 

		(ii)	making applications for all other forms of Intellectual Property registration relating to all Work Product;

 

		(iii)	prosecuting and maintaining the patent applications and other Intellectual Property relating to all Work
Product; and

 

		(iv)	registering, maintaining and enforcing the patents and other Intellectual Property registrations relating
to all Work Product.

 

		(v)	If the Company is unable for any reason to secure the Employee’s signature with respect to any Work
Product including, without limitation, to apply for or to pursue any application for any patents or copyright registrations covering such
Work Product, then the Employee hereby irrevocably designates and appoints the Company and its duly authorized officers and agents as
their agent and attorney-in-fact, to act for and in their behalf and stead to execute and file any papers, oaths and to do all other lawfully
permitted acts with respect to such Work Product with the same legal force and effect as if executed by them.

 

		(g)	Assistance with Proceedings. The Employee will reasonably assist the Company, at the Company’s
request and expense, in connection with any defence to an allegation of infringement of another person’s intellectual property rights,
claim of invalidity of another person’s intellectual property rights, opposition to, or intervention regarding, an application for
letters patent, copyright or trademark or other proceedings relating to Intellectual Property or applications for registration thereof.

 

		(h)	Commercialization. The Employee understands that the decision whether or not to commercialize or
market any Work Product is within the Company’s sole discretion and for the Company’s sole benefit and that no royalty or
other consideration will be due or payable to him as a result of the Company’s efforts to commercialize or market any such Work
Product.

 

		(i)	Prior Business Intellectual Property. The Employee represents and warrants to the Company that
they have not brought or used, and the Employee covenants and agrees that they will not use or bring to the Company any Intellectual Property
of any kind whatsoever of any Prior Business with whom the Employee had a Prior Involvement or any Intellectual Property directly owned
by the Employee. The Company and the Employee acknowledge and agree that the Company is not employing the Employee to obtain Intellectual
Property relating to any Prior Involvement and the Employee acknowledges that the Company has advised the Employee to comply with any
legal obligations the Employee may have to such Prior Business. The Employee covenants and agrees to indemnify and hold the Company harmless
from any and all losses, claims, damages, expenses, and costs (including legal costs on a solicitor-client basis) of any kind whatsoever
that the Company may suffer related to any breach by the Employee of their obligations to such Prior Business in that regard.

 

    Page 18 of 28

     

    

 

		(j)	Prior Inventions. In order to have them excluded from this Exhibit B, the Employee has set forth
on Attachment 1 attached to this Exhibit B a complete list of all Inventions for which a patent application has not yet been filed that
they have, alone or jointly with others, conceived, developed or reduced to practice prior to the execution of this Exhibit B to which
they have any right, title or interest, and which relate to the Business of the Company. If such list is blank or no such list is attached,
the Employee represents and warrants that there are no such prior Inventions.

 

		4	PUBLICITY

 

The Employee shall
not, without the prior written consent of the Company, make or give any public announcements, press releases or statements to the public
or the press regarding any Work Product or any Confidential Information.

 

		5	FURTHER ASSURANCES

 

The Parties will execute
and deliver to each other such further instruments and assurances and do such further acts as may be required to give effect to this Exhibit
B.

 

		6	FIDUCIARY STATUS

 

The provisions of
this Exhibit B are additional to and do not amend, replace or otherwise reduce the Employee’s fiduciary obligations at law or equity.

 

		7	TERMINATION OF EMPLOYMENT / SURVIVAL

 

		(a)	The covenants in this Exhibit B apply regardless of which Party initiated the termination of the Employee’s
employment or the reasons for the termination of the Employee’s employment.

 

		(b)	If the employment of the Employee is terminated for any reason by the Employee or the Company and there
is any dispute with respect to whether any obligations have been breached or to what extent compensation or other entitlements are owing
to the Employee then despite the dispute and whether the Company is, or is later determined to be, otherwise in compliance with the terms
and conditions of the Employee’s employment, the Employee will at all times remain bound by the post-employment obligations set
out in this Exhibit B.

 

		(c)	This Exhibit B will survive the termination of employment of the Employee for any reason and will continue
in full force and effect.

 

		8	NO CONFLICTING OBLIGATIONS

 

The Employee hereby
represents and warrants that the Employee has no agreements with or obligations to any other person with respect to the matters covered
by this Exhibit B or concerning the Confidential Information that are in conflict with anything in this Exhibit B, except as disclosed
in Attachment 1 attached to this Exhibit B.

 

    Page 19 of 28

     

    

 

		9	SEVERABILITY

 

For the purposes of section
9(e) of the EA, each covenant or obligation set out in this Exhibit B is a separate and distinct provision.

 

		10	INDEPENDENT LEGAL ADVICE

 

The Employee agrees that the
Employee has obtained or has had an opportunity to obtain independent legal advice in connection with this Exhibit B, and further acknowledges
that the Employee has read, understands, and agrees to be bound by all of the terms and conditions contained herein.

 

	Agreed:	 		 	Date: _________________, 2021	 
	 	 	 	 	 	 
	SARAH LI 	 	 	 

 

	Agreed:	 	                                                    	 	 Date: _________________, 2021	 
	 	 	 	 	 	 
		 	INMED PHARMACEUTICALS INC.	 	 	 

 

    Page 20 of 28

     

    

 

Attachment 1 to Exhibit B

 

EXCLUSIONS FROM WORK PRODUCT

 

		●	Nil.

 

    Page 21 of 28

     

    

 

Exhibit C –
Restrictive Covenant Agreement

 

Dated: March 1,
2021

 

		WHEREAS:	

 

		A.	In accordance with the terms of the Employment Agreement between the Employee and the Company dated March
1, 2021 (the “EA”), the Employee has agreed to execute this Restrictive Covenant Agreement on the terms set out herein.

 

NOW THEREFORE for good and valuable
consideration, including the consideration contemplated by the EA, the receipt and sufficiency of which is acknowledged by the Employee,
the Employee and the Company agree as follows:

 

		1	INTERPRETATION

 

The capitalized terms
have the meanings ascribed to them in the EA, and the following terms have the following meanings:

 

		(a)	“Business” or “Business of the Company” means researching, developing,
commercializing, producing and marketing novel, cannabinoid-based and other pharmaceutical therapies to treat disease combined with innovative
drug delivery systems;

 

		(b)	“Capacity” means as a principal, agent, employee, director, officer, advisor, shareholder,
consultant or contractor.

 

		(c)	“Competing Business” means any endeavor, activity or business which is competitive
in any material way with the Business of the Company worldwide;

 

		(d)	“Competitive Duties” means any duties that:

 

		(i)	are the same or similar to any of the duties the Employee performed for the Company in the 18-month period
immediately preceding the Date of Termination and relate to products and/or services that are competitive with the Business of the Company,
or

 

		(ii)	involve the management, direction or supervision of personnel performing any of the duties described in
paragraph (i) above;

 

		(e)	“Contact” means any person, firm, corporation or other entity that was a client, customer,
supplier, principal, shareholder, investor, collaborator, strategic partner, licensee, contact or prospect of the Company (or of its partners
or funders) with whom the Employee materially dealt or otherwise became aware of during the term of the Employee’s employment in
any capacity with the Company;

 

		(f)	“Restricted Period” means the 12-month period immediately following the Date of Termination;

 

		(g)	“Prohibited Work” means any Employee, management, supervisory, consultation or strategic
work for a Competing Business in circumstances where the Employee has Confidential Information, or had been given Confidential Information,
that if used or disclosed in performing such work could be advantageous to the Competing Business in competing with the Business; and

 

    Page 22 of 28

     

    

 

		(h)	“Restricted Territory” means the United States of America and Canada and the geographic
area in any other country in which the Company had material business relationships in which the Employee was materially involved at the
time of or within 12 months of the Date of Termination.

 

		2	ACKNOWLEDGEMENT

 

The Employee acknowledges
the following:

 

		(a)	The Business of the Company is highly competitive;

 

		(b)	The Employee has had and will continue to have a Employee role for the Company, has had and will continue
to have extensive access to, and has been and will continue to be entrusted with, highly sensitive Confidential Information and has been
and will continue to be involved in and responsible for strategic, supervisory and managerial decisions for the Company;

 

		(c)	The Employee has developed and will continue to develop important relationships with key Contacts such
that the goodwill and competitiveness of the Business of the Company depend in part on the Employee; and

 

		(d)	As a result, the Company would be vulnerable to and harmed by the Employee performing duties and work
that are competitive with or detrimental to the Company for a reasonable period after the Date of Termination.

 

		3	NON-COMPETITION

 

		(a)	Restriction. During the Restricted Period, the Employee shall not, without the prior written consent
of the Board acting reasonably, directly or indirectly, perform Competitive Duties or Prohibited Work for a Competing Business in any
Capacity within the Restricted Territory.

 

		(b)	Exception. Nothing in subsection (a) above shall prohibit the Employee from, during the Restricted
Period, holding, strictly for portfolio purposes and as a passive investor, no more than five percent (5%) of the issued and outstanding
shares of, or any other interest in, any corporation or other entity which is listed on any recognized stock exchange, that is a Competing
Business.

 

		4	NON-SOLICITATION OF CONTACTS

 

		(a)	Restriction. During the Restricted Period the Employee shall not directly or indirectly in a manner
that is competitive with the Business of the Company:

 

		(i)	participate in any bid or tender process with respect to, or

 

		(ii)	solicit or otherwise interfere with the relationship with the Company with

 

any Contact in the Restricted
Territory.

 

		(b)	Exception. The restriction in paragraph (a) does not apply to solicitation through broadly circulated
media advertisements that are generic in nature.

 

    Page 23 of 28

     

    

 

		5	NON-SOLICITATION OF PERSONNEL

 

		(a)	Restriction. During the Restricted Period the Employee shall not directly or indirectly solicit
or entice any person who is an employee or contractor of the Company to leave employment or engagement with the Company.

 

		(b)	Exception. The restriction in paragraph (a) does not apply to solicitation through broadly circulated
media advertisements that are generic in nature.

 

		6	RELATIONSHIP WITH A COMPETITIVE BUSINESS

 

If the Employee has
any direct or indirect relationship with a Competitive Business any time during the Restricted Period, then the Employee will have the
duty and responsibility to promptly notify the Company of such relationship and cooperate in any investigation by the Company as to whether
the Employee is or will be in breach of any obligation in this Exhibit C. The Employee will promptly cooperate and comply with any requests
from any of the Company for information or documentation related to any such relationship with a Competitive Business.

 

		7	REASONABLENESS

 

The Employee agrees
and acknowledges that the covenants and obligations in this Exhibit C are given for good and valuable consideration, paid or provided
in exchange for agreeing to the restrictions set out in this Exhibit C and that by reason of the Employee’s unique knowledge of
and relationship with the Company and the significant competitive relationship between the Company and the Competing Businesses, the scope
of these covenants and obligations as to time, activity and geographic area, the definitions of Competing Business, Competitive Duties,
Prohibited Work, Restricted Period, and Restricted Territory are reasonable and give only such reasonable restrictions as are minimally
necessary to protect the legitimate proprietary interests of the Company. The Employee further agrees and acknowledges that the Company
may notify any employer or prospective employer of the Employee, and any other legal entity with whom the Employee has had or is having
direct or indirect dealings with, of the restrictions set out in this Exhibit C when reasonably required by the Company to protect its
legitimate business interests.

 

		8	FIDUCIARY STATUS

 

The provisions of
this Exhibit C are additional to and do not amend, replace or otherwise reduce the Employee’s fiduciary obligations at law or equity.

 

		9	TERMINATION OF EMPLOYMENT / SURVIVAL

 

		(a)	The covenants in this Exhibit C apply regardless of which Party initiated the termination of the Employee’s
employment or the reasons for the termination of the Employee’s employment.

 

		(b)	If the employment of the Employee is terminated for any reason by the Employee or the Company and there
is any dispute with respect to whether any obligations have been breached or to what extent compensation or other entitlements are owing
to the Employee then despite the dispute and whether the Company is, or is later determined to be, otherwise in compliance with the terms
and conditions of the Employee’s employment, the Employee will at all times remain bound by the post-employment obligations set
out in this Exhibit C.

 

		(c)	This Exhibit C will survive the termination of employment of the Employee for any reason and will continue
in full force and effect.

 

    Page 24 of 28

     

    

 

		10	NO CONFLICTING OBLIGATIONS

 

The Employee hereby
represents and warrants that they have no agreements with or obligations to any other person with respect to the matters covered by this
Exhibit C.

 

		11	SEVERABILITY

 

For the purposes of
section 9(e) of the EA, each covenant or obligation set out in this Exhibit C is a separate and distinct provision.

 

		12	INDEPENDENT LEGAL ADVICE

 

The Employee agrees
that the Employee has obtained or has had an opportunity to obtain independent legal advice in connection with this Exhibit C, and further
acknowledges that the Employee has read, understands, and agrees to be bound by all of the terms and conditions contained herein.

 

	Agreed:	 	 	 	Date:
_________________, 2021	 
	 	 	 
	SARAH LI	 	 

 

	Agreed:	 	                                                    	 	 Date: _________________, 2021	 
	 	 	 	 	 	 
		 	INMED PHARMACEUTICALS INC.	 	 	 

 

    Page 25 of 28

     

    

 

Exhibit D –
Release

 

FOR AND IN CONSIDERATION OF the terms set
out in the Employment Agreement dated March 1, 2021 (the “EA”) and other good and valuable consideration, SARAH
LI  (the “Employee”) agrees to remise, release and forever discharge of INMED PHARMACEUTICALS INC. (the
“Company”), and the Company’s associated or related entities, subsidiaries, predecessors, successors, assigns,
officers, owners, operators, directors, employees, insurers and agents and each of their associated or related entities, subsidiaries,
predecessors, successors, assigns, officers, owners, operators, directors, employees, insurers and agents and each of their respective
predecessors, successors, heirs, executors, administrators, and assigns from any and all manner of actions, causes of action, suits, debts,
damages, covenants, contracts, costs, expenses, compensation, claims and demands whatsoever, whether in law or in equity, whether known
or unknown, relating to the Employee’s employment with the Company or the cessation of that employment, and without limiting the
generality of the foregoing, any claims or rights under the Employment Standards Act (British Columbia) and the Human Rights
Code (British Columbia) and any other applicable provincial or federal legislation (to the maximum extent permitted by such legislation),
any claims for severance pay or pay in lieu of notice of termination, damages for loss of reputation, loss of position, loss of status,
loss of future job opportunities, and constructive termination, any claims arising from the manner and timing of the termination, and
any claims or rights under the weekly indemnity, long term disability, incentive and other benefit plans of the Company.

 

Except for amounts to be paid or benefits and
other entitlements to be provided to the Employee pursuant to the express terms of the EA after the date of execution of this Release,
the Employee agrees and acknowledges that:

 

		(a)	the Employee has received, or by virtue of the terms of the EA will receive, all wages including, without
limiting the generality of the foregoing, overtime pay, vacation pay, general holiday pay and pay in respect of termination of employment
to which the Employee is entitled under the Employment Standards Act as of the date of this Release;

 

		(b)	the Company has, or by virtue of the terms of the EA will have, satisfied all obligations to the Employee
under the Employment Standards Act in relation to the Employee’s employment and the cessation of the Employee’s employment,
and there is no factual or legal basis for any claim or entitlement against the Company under that statute;

 

		(c)	the payments to the Employee by or on behalf of the Company are not to be construed as an admission of
liability on the part of the Company, which liability is expressly denied;

 

		(d)	this Release is executed by the Employee for the purpose of making a full, final and irrevocable settlement
of any and all claims whatsoever and howsoever arising against the Company;

 

		(e)	the Employee will not make any further claim or take any proceedings whatsoever against the Company or
any other person, company or other legal entity who might claim contribution or indemnity from the Company in respect of matters which
are the subject of this Release;

 

    Page 26 of 28

     

    

 

		(f)	the facts in respect of which this Release is made may prove to be other than or different from the facts
now known or believed to be true, and the Employee expressly accepts and assumes the risk of the facts being different, and agrees that
this Release will be in all respects enforceable and not subject to termination, rescission, or variation by discovery of any difference
in facts;

 

		(g)	the Employee will indemnify and hold harmless the Company from all liability, if any, for any tax, penalty,
interest or any other amount of any kind whatsoever arising under any one or more of the Income Tax Act (Canada), the Employment
Insurance Act (Canada), the Canada Pension Plan Act (Canada), and any other similar statute of Canada or a province or territory
thereof, that arises in consequence of the performance of the obligations to the Employee by or on behalf of the Company;

 

		(h)	the existence and terms of the settlement between the Employee and the Company and this Release are confidential
and the Employee will not disclose, except as required by law, either the whole or part of such settlement or Release to anyone, but disclosure
may be made to the Employee’s legal or financial advisors and spouse, on the condition that the Employee will ensure that those
persons to whom the Employee makes disclosure maintain that confidentiality and do not disclose the existence and terms of the settlement;

 

		(i)	this Release is voluntarily executed and the terms of the Release are contractual and not a mere recital;
and

 

		(j)	the Employee had read and understands this Release and has, prior to the execution hereof, had the opportunity
to receive independent legal advice in respect hereof.

 

    Page 27 of 28

     

    

 

IN WITNESS WHEREOF SARAH LI HAS SIGNED
THIS RELEASE THIS ___ DAY OF _________________, 20__.

 

	 	 
	 	 
	SARAH LI	 

 

 

Page 28 of 28EX-10.1

  Exhibit 10.1

  SECOND AMENDMENT
TO
NUTANIX, INC. SECOND AMENDED AND RESTATED OUTSIDE DIRECTOR COMPENSATION POLICY

  Adopted and approved September 26, 2022

   

  The Nutanix, Inc. Second Amended and Restated Outside Director Compensation Policy, effective June 16, 2021 and as amended by the First Amendment effective March 30, 2022 (the “Policy”), is hereby amended as follows:

  1. Section 1 of the Policy is hereby amended by replacing “$87,500” opposite “Non‐Executive Board Chair:” with “$107,500”.

  2. Except as otherwise amended, the Policy is hereby confirmed in all other respects.

  3. This Second Amendment is effective as of September 26, 2022.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]